GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (MEX:BSX) » Definitions » Cyclically Adjusted Revenue per Share

Boston Scientific (MEX:BSX) Cyclically Adjusted Revenue per Share : MXN143.28 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Boston Scientific Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Boston Scientific's adjusted revenue per share for the three months ended in Mar. 2024 was MXN43.190. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN143.28 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Boston Scientific's average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Boston Scientific was 16.80% per year. The lowest was -2.90% per year. And the median was 4.20% per year.

As of today (2024-06-27), Boston Scientific's current stock price is MXN1409.00. Boston Scientific's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was MXN143.28. Boston Scientific's Cyclically Adjusted PS Ratio of today is 9.83.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Boston Scientific was 8.95. The lowest was 1.46. And the median was 5.34.


Boston Scientific Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Boston Scientific's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Cyclically Adjusted Revenue per Share Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.43 123.33 150.98 157.84 138.55

Boston Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.47 142.26 145.43 138.55 143.28

Competitive Comparison of Boston Scientific's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PS Ratio falls into.



Boston Scientific Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boston Scientific's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=43.19/131.7762*131.7762
=43.190

Current CPI (Mar. 2024) = 131.7762.

Boston Scientific Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 18.061 100.560 23.668
201409 18.393 100.428 24.134
201412 20.979 99.070 27.905
201503 20.209 99.621 26.732
201506 21.234 100.684 27.791
201509 23.738 100.392 31.159
201512 25.274 99.792 33.374
201603 24.679 100.470 32.369
201606 28.965 101.688 37.535
201609 29.500 101.861 38.164
201612 32.636 101.863 42.220
201703 29.255 102.862 37.478
201706 29.328 103.349 37.395
201709 28.925 104.136 36.603
201712 33.891 104.011 42.938
201803 30.943 105.290 38.727
201806 34.976 106.317 43.352
201809 31.883 106.507 39.447
201812 35.760 105.998 44.457
201903 34.336 107.251 42.188
201906 35.879 108.070 43.750
201909 37.843 108.329 46.034
201912 38.753 108.420 47.101
202003 42.185 108.902 51.046
202006 32.769 108.767 39.701
202009 41.051 109.815 49.261
202012 37.742 109.897 45.256
202103 39.316 111.754 46.360
202106 42.758 114.631 49.153
202109 41.995 115.734 47.816
202112 44.665 117.630 50.037
202203 41.887 121.301 45.504
202206 45.391 125.017 47.845
202209 44.281 125.227 46.597
202212 43.811 125.222 46.104
202303 42.245 127.348 43.714
202306 42.371 128.729 43.374
202309 41.652 129.860 42.267
202312 42.818 129.419 43.598
202403 43.190 131.776 43.190

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Boston Scientific  (MEX:BSX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Boston Scientific's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1409.00/143.28
=9.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Boston Scientific was 8.95. The lowest was 1.46. And the median was 5.34.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Boston Scientific Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (MEX:BSX) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.